France· FR:66198796
ISORYTHM L.P. 125 mg, gélule à libération prolongée
A medicinal product containing disopyramide (phosphate de), registered in France by SERP, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- DISOPYRAMIDE (PHOSPHATE DE)
- Manufacturer
- SERP
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400932989393plaquette(s) thermoformée(s) PVC-Aluminium de 20 gélule(s)EUR 3.3
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Disopyramide (phosphate de) in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDirythmin SA 150mg tabletsAstraZeneca UK Ltd
- United StatesDisopyramide PhosphateMylan Pharmaceuticals Inc.
- NorwayRitmodan RetardSanofi
- ItalyRITMODAN RETARD*20 cpr 250 mgCHEPLAPHARM ARZNEIMITTEL GMBH
- BelgiumRythmodan 100 mgCheplapharm Arzneimittel
- FinlandDurbisHoechst Marion Roussel AB
- NetherlandsRitmoforine Retard 250 mg, tabletten met gereguleerde afgifteCHEPLAPHARM Arzneimittel GmbH
- CanadaRYTHMODANCHEPLAPHARM ARZNEIMITTEL GMBH
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Belgium · Rythmodan, Rythmodan Long Action
- Spain · Dicorynan
- United Kingdom (Northern Ireland) · Disopyramide Neon, Disopyramide Neon Healthcare
- Italy · Ritmodan, Ritmodan Retard
- Luxembourg · Rythmodan, Rythmodan Long Action
- Netherlands · Ritmoforine Retard
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7b6064e5-8b36-4569-8850-0ea0bed25726 GET /v1/drugs/7b6064e5-8b36-4569-8850-0ea0bed25726?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66198796",
"date_amm": "1987-09-21",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "DISOPYRAMIDE (PHOSPHATE DE)",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "gélule à libération prolongée",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about disopyramide (phosphate de).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.